An article published in JAMA outlines the use of a biomarker to identify patients that have experienced a heart attack, enabling physicians to undertake aggressive treatment immediately. Till Keller, M.D., of the University Heart Center Hamburg, Germany, and colleagues evaluated the diagnostic performance of the newly developed highly sensitive troponin I (hsTnI) assay compared with a contemporary troponin I (cTnI) assay and their serial changes in the diagnosis of heart attack...
doctor oz
No comments:
Post a Comment